Skip to content

CapEx at other companies

Eli Lilly logo
Eli LillyLLY
$2.33B+54.0%
Amgen logo
AmgenAMGN
$712M+73.2%
Amylyx Pharmaceuticals, Inc. logo
Amylyx Pharmaceuticals, Inc.AMLX
$86K+330%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$69K
Nurix Therapeutics, Inc. logo
Nurix Therapeutics, Inc.NRIX
$1.05M-70.0%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$820K-33.8%

Other financials

Income statement

See full
Operating income-$27.3M-2.8%
Net income-$23.5M+1.5%
EPS (diluted)-$0.50+29.6%

Balance sheet

See full
Cash & equivalents$45.2M+51.2%
Total debt$555.0K+327%
Total equity$437.8M+85.9%
Total assets$452.7M+84.1%

Cash flow

See full
Operating cash flow-$20.2M+10.9%
Free cash flow-$20.6M+9.1%

Valuation

See full
Market cap$2.21B+475%
Enterprise value$2.16B+533%

Returns & leverage

See full
Return on equity-25.7%
Debt / equity0.0×
Current ratio30.8×+7.5×

Where this comes from

Reported directly by MBX Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about MBX Biosciences, Inc.'s capex.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MBX Biosciences, Inc.'s capex?
MBX Biosciences, Inc. (MBX) reported capex of $437K in Q1 2026.
How has MBX Biosciences, Inc.'s capex changed year-over-year?
MBX Biosciences, Inc.'s capex increased by 1356.7% year-over-year, from $30K to $437K.
What does capex mean?
Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.